Genetic test + MRI: a better way to spot dangerous prostate cancer?

NCT ID NCT06398639

Summary

This study aims to find a better way to screen for serious prostate cancer. Researchers will test 1,500 men aged 40-69 by combining a genetic risk score with a special MRI scan. The goal is to see if this two-step method can more accurately identify high-grade cancers that need treatment, while reducing unnecessary testing for low-risk men.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02155, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Howard University Hospital

    NOT_YET_RECRUITING

    Washington D.C., District of Columbia, 20060, United States

    Contact

    Contact

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Institute

    NOT_YET_RECRUITING

    Bethesda, Maryland, 20814, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Walter Reed National Military Medical Center

    NOT_YET_RECRUITING

    Bethesda, Maryland, 20814, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.